Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Inv. presentation
Acq. announced
Appointed director
INSMED Inc (INSM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update"
07/11/2023 144 Form 144 - Report of proposed sale of securities:
07/07/2023 8-K/A Submission of Matters to a Vote of Security Holders  Interactive Data
05/19/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/19/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/11/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated Bylaws of the Company (effective as of May 11, 2023)"
05/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, “The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More”",
"Insmed Incorporated May 8, 2023 Presentation"
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
03/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/31/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/23/2023 10-K Annual Report for the period ended December 31, 2022
02/23/2023 8-K Quarterly results
02/14/2023 SC 13G T. Rowe Price Investment Management, Inc. reports a 6.2% stake in INSMED INC
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 7.4% stake in INSMED INC
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.6% stake in Insmed Inc.
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 SC 13G STATE STREET CORP reports a 5.1% stake in INITIAL FILING INSMED INC
01/12/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/06/2023 8-K Quarterly results
10/27/2022 8-K Quarterly results
10/27/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/20/2022 8-K Quarterly results
10/19/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/19/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy